310 related articles for article (PubMed ID: 10811618)
1. Structural basis of the Axin-adenomatous polyposis coli interaction.
Spink KE; Polakis P; Weis WI
EMBO J; 2000 May; 19(10):2270-9. PubMed ID: 10811618
[TBL] [Abstract][Full Text] [Related]
2. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
[TBL] [Abstract][Full Text] [Related]
3. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
[TBL] [Abstract][Full Text] [Related]
4. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex.
Dajani R; Fraser E; Roe SM; Yeo M; Good VM; Thompson V; Dale TC; Pearl LH
EMBO J; 2003 Feb; 22(3):494-501. PubMed ID: 12554650
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.
Behrens J; Jerchow BA; Würtele M; Grimm J; Asbrand C; Wirtz R; Kühl M; Wedlich D; Birchmeier W
Science; 1998 Apr; 280(5363):596-9. PubMed ID: 9554852
[TBL] [Abstract][Full Text] [Related]
7. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.
Farr GH; Ferkey DM; Yost C; Pierce SB; Weaver C; Kimelman D
J Cell Biol; 2000 Feb; 148(4):691-702. PubMed ID: 10684251
[TBL] [Abstract][Full Text] [Related]
8. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin.
Kishida S; Yamamoto H; Ikeda S; Kishida M; Sakamoto I; Koyama S; Kikuchi A
J Biol Chem; 1998 May; 273(18):10823-6. PubMed ID: 9556553
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a beta-catenin/axin complex suggests a mechanism for the beta-catenin destruction complex.
Xing Y; Clements WK; Kimelman D; Xu W
Genes Dev; 2003 Nov; 17(22):2753-64. PubMed ID: 14600025
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.
Hart MJ; de los Santos R; Albert IN; Rubinfeld B; Polakis P
Curr Biol; 1998 May; 8(10):573-81. PubMed ID: 9601641
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
[TBL] [Abstract][Full Text] [Related]
12. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.
Hinoi T; Yamamoto H; Kishida M; Takada S; Kishida S; Kikuchi A
J Biol Chem; 2000 Nov; 275(44):34399-406. PubMed ID: 10906131
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Wnt signaling by Axin and Axil.
Kikuchi A
Cytokine Growth Factor Rev; 1999; 10(3-4):255-65. PubMed ID: 10647780
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of beta-catenin by the colorectal tumor suppressor APC requires association with Axin and beta-catenin.
Kawahara K; Morishita T; Nakamura T; Hamada F; Toyoshima K; Akiyama T
J Biol Chem; 2000 Mar; 275(12):8369-74. PubMed ID: 10722668
[TBL] [Abstract][Full Text] [Related]
15. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
Schneikert J; Ruppert JG; Behrens J; Wenzel EM
PLoS One; 2014; 9(4):e94413. PubMed ID: 24722208
[TBL] [Abstract][Full Text] [Related]
16. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
Sakanaka C; Weiss JB; Williams LT
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
[TBL] [Abstract][Full Text] [Related]
17. Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by Axin.
Choi J; Park SY; Costantini F; Jho EH; Joo CK
J Biol Chem; 2004 Nov; 279(47):49188-98. PubMed ID: 15355978
[TBL] [Abstract][Full Text] [Related]
18. Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts.
Salic A; Lee E; Mayer L; Kirschner MW
Mol Cell; 2000 Mar; 5(3):523-32. PubMed ID: 10882137
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Wnt signaling pathway by a novel axin-binding protein.
Kadoya T; Kishida S; Fukui A; Hinoi T; Michiue T; Asashima M; Kikuchi A
J Biol Chem; 2000 Nov; 275(47):37030-7. PubMed ID: 10944533
[TBL] [Abstract][Full Text] [Related]
20. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
